Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 981 | 771 | 727 | 736 | 569 | 474 | 414 | 433 | 437 | 397 | 395 |
Expenses | 877 | 656 | 631 | 570 | 478 | 426 | 355 | 373 | 314 | 270 | 275 |
EBITDA  | 104 | 115 | 96 | 166 | 91 | 48 | 60 | 60 | 123 | 127 | 121 |
Operating Profit % | -0 % | 5 % | 4 % | -1 % | 3 % | 3 % | 7 % | 7 % | 17 % | 19 % | 22 % |
Depreciation | 4 | 4 | 4 | 3 | 3 | 13 | 12 | 10 | 6 | 3 | 2 |
Interest | 0 | 0 | 1 | 6 | 2 | 6 | 8 | 5 | 2 | 2 | 1 |
Profit Before Tax  | 93 | 111 | 92 | 158 | 86 | 29 | 40 | -4 | 115 | 123 | 118 |
Tax | 14 | 39 | 35 | 79 | 34 | 19 | 19 | -0 | 12 | 38 | 31 |
Net Profit | 79 | 73 | 57 | 78 | 52 | 10 | 21 | -4 | 103 | 85 | 86 |
EPS in ₹ | 24.75 | 62.04 | 19.10 | 28.43 | 20.97 | 4.08 | 8.46 | -1.51 | 41.86 | 34.50 | 35.00 |
Above figures are in Rs. Crores Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Total Assets  | 1,246 | 1,433 | 1,150 | 1,111 | 982 | 1,078 | 1,002 | 958 | 983 | 925 |
Fixed Assets | 9 | 7 | 6 | 5 | 15 | 76 | 64 | 24 | 19 | 7 |
Current Assets | 1,063 | 1,264 | 973 | 952 | 807 | 813 | 723 | 709 | 677 | 699 |
Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 1,238 | 1,426 | 1,144 | 1,106 | 968 | 1,001 | 938 | 934 | 964 | 918 |
Total Liabilities  | 1,246 | 1,433 | 1,150 | 1,111 | 982 | 1,078 | 1,002 | 958 | 983 | 925 |
Current Liabilities | 211 | 205 | 183 | 330 | 185 | 233 | 159 | 216 | 160 | 157 |
Non Current Liabilities | 33 | 35 | 47 | 47 | 38 | 124 | 132 | 50 | 48 | 23 |
Total Equity  | 1,002 | 1,194 | 920 | 734 | 759 | 721 | 711 | 692 | 776 | 745 |
Reserve & Surplus | 986 | 1,178 | 906 | 721 | 747 | 708 | 699 | 679 | 763 | 733 |
Share Capital | 16 | 16 | 14 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Above figures are in Rs. Crores Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Net Cash Flow | 622 | -613 | 51 | -38 | 50 | -9 | -11 | 90 | -139 | 26 |
Investing Activities | 719 | -631 | 424 | 69 | 274 | 56 | 95 | 87 | -153 | 33 |
Operating Activities | -60 | 57 | -41 | 161 | -194 | -23 | -69 | 39 | 45 | 113 |
Financing Activities | -38 | -39 | -332 | -268 | -30 | -41 | -37 | -36 | -31 | -121 |
Above figures are in Rs. Crores % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Promoter | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % | 70.68 % |
FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.32 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % | 0.19 % |
DIIs | 0.79 % | 0.84 % | 0.78 % | 0.78 % | 0.78 % | 0.78 % | 0.79 % | 0.79 % | 0.78 % | 0.76 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % | 0.53 % |
Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
Public / Retail | 23.34 % | 23.03 % | 23.09 % | 22.98 % | 22.88 % | 22.94 % | 23.02 % | 23.01 % | 23.03 % | 23.08 % | 23.29 % | 23.21 % | 22.95 % | 23.04 % | 23.05 % | 23.01 % | 23.11 % |
Others | 5.20 % | 5.46 % | 5.45 % | 5.56 % | 5.66 % | 5.60 % | 5.52 % | 5.52 % | 5.51 % | 5.48 % | 5.18 % | 5.39 % | 5.65 % | 5.57 % | 5.55 % | 5.59 % | 5.49 % |
No of Share Holders | 41,572 | 43,784 | 45,141 | 44,640 | 44,370 | 43,996 | 43,275 | 42,622 | 41,947 | 43,343 | 43,992 | 43,128 | 41,239 | 39,265 | 39,596 | 38,926 | 39,133 |
Dividend Per Share (₹) | 0.00 | 10 | 10 | 10 | 10 | 10 | 10 | 47.5 | 25 | 0.00 |
Dividend Yield (%) | 0.00 | 1.63 | 1.46 | 1.99 | 1.81 | 1.69 | 1.76 | 4.62 | 3.18 | 0.00 |
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
4 days ago Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Apr 14, 2025 Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011.
Apr 03, 2025 Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011.
Apr 03, 2025 Filing Of Intimation Under Regulation 30 For The Receipt Of Draft Tax Assessment Order By The Company
Mar 27, 2025 Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday May 09 2025.
Mar 27, 2025 Closure of Trading Window
Mar 27, 2025 Integrated Filing (Financial)
Mar 04, 2025 This Is To Inform That The Company Has Received Order From Assistant Commissioner Of CGST And Central Excise And Disclosure Is Given Pursuant To Regulation 30 Read With Clause 20 Of Para A Of Schedule
Feb 20, 2025 Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 29, 2025 Filing Of Unaudited Financial Results And Limited Review Report For The Quarter And Nine Months Ended December 31 2024
Jan 28, 2025 Board Meeting Outcome for Filing Of Outcome Of The Meeting Of Board Of Directors Of Novartis India Limited Held On January 28 2024
Jan 28, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 10, 2025 Board Meeting Intimation for Approval Of Quarterly Financial Results For The Quarter Ended As On December 31 2024. The Board Meeting Shall Be Held On Tuesday January 28 2025.
Dec 27, 2024 Closure of Trading Window
Dec 27, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 27, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 05, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 04, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 28, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 21, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 20, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 15, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 14, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 14, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 14, 2024 Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 28, 2024 Filing Of The Outcome Of Board Meeting And Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
Oct 25, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 24, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 24, 2024 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 11, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 09, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 30, 2024 Board Meeting Intimation for Board Meeting Intimation For The Consideration And Approval Of Unaudited Financial Results For The Quarter Ended September 30, 2024.
Sep 27, 2024 Closure of Trading Window
Sep 27, 2024 Filing Of Clarification On The Email Received From BSE Dated September 26, 2024, On The Rumor In Relation To Acquisition Of Novartis India Limited From Its Swiss Parent Company By Alkem Labs
Sep 26, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 26, 2024 Clarification sought from Novartis India Ltd
Sep 26, 2024 Intimation Of Acquiring Of DESFERAL® (Deferoxamine) Globally From Novartis Pharma AG By Mitem Pharma. The Disclosure In This Regard Is Made By Mitem Pharma Through Press Release Over Businesswire On September 25, 2024.
Sep 25, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 23, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 12, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 12, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 09, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 02, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 30, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 29, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 26, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 20, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 16, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 11, 2024 Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 05, 2024 RSI(14)

Neutral
51.88
ATR(14)

Volatile
26.89
STOCH(9,6)

Neutral
73.96
STOCH RSI(14)

Neutral
68.36
MACD(12,26)

Bullish
3.84
ADX(14)

Weak Trend
14.61
UO(9)

Bearish
47.21
ROC(12)

Uptrend And Accelerating
1.91
WillR(14)

Neutral
-42.78